FDA Head Pressed On Infant Formula Shortage, Abbott Plant
The head of the U.S. Food and Drug Administration on Thursday faced sharp questions from lawmakers about the agency's handling of a closed Abbott baby formula plant under agency investigation for...To view the full article, register now.
Already a subscriber? Click here to view full article